Keywords

1 Introduction

The body responds to high-altitude hypoxia with molecular, cellular, and systemic adaptations (West 2012; Bosco et al. 2003; Cerretelli and Di Prampero 1987; Pugh 1962) across cardiovascular (Kylhammar and Rådegran 2017; Luks et al. 2017; Verratti et al. 2015), respiratory (Beretta et al. 2017), musculoskeletal (Bosco et al. 2010; Doria et al. 2011), hormonal (Verratti et al. 2017; Pelliccione et al. 2011), reproductive (Verratti et al. 2011), and metabolic (Boos et al. 2013; San et al. 2013) organ systems. Exercise performance and muscle damage and regeneration in the hypoxic condition have been extensively studied (Sumi et al. 2018; Mancinelli et al. 2016). However, the underlying mechanisms of muscle dysfunction and the significance of enhanced serum creatine kinase content following physical exercise are unsettled (Baird et al. 2012). A combination of hypoxia and physical strain may induce an inflammatory response, which is reflected by enhanced serum C-reactive protein (Li and Fang 2004; Hartmann et al. 2000). Hypoxia also affects oxidative metabolism, stimulating the process of oxygen transport and storage to ensuring adequate tissue oxygenation (Verratti et al. 2009; Di Giulio et al. 2006).

It is known that long-term exposure to high altitude causes a marked reduction in body mass, which involves both the lean and fat components (Cacciani et al. 2008; Rose et al. 1988). Exposure to hypobaric hypoxia changes the attitude toward eating by decreasing appetite and food intake (Westerterp-Plantenga et al. 1999), leading to a negative energy balance (Richalet 2010). Another cause of reduced appetite is a negative feedback system between adipocytes and the hypothalamus, which increases leptin content and energy expenditure (Paoli et al. 2014, 2015). Studies show that leptin alters the neuroendocrine regulation, inducing a loss of appetite and increased energy expenditure which lead to weight loss (Palmer and Clegg 2014; Petousi et al. 2014; Vats et al. 2007; Tschop et al. 1998). Decreased protein intake, associated with physical stress, is a central anabolic stimulus for muscles, which is conducive to sarcopenia (Yanai 2015).

In view of the phenomena above outlined, the present study seeks to define metabolic and endocrine adaptations to high-altitude hypoxia, associated with physical strain due to extensive trekking, in an attempt to get insight into the protective role of a high-protein diet on the sarcopenia related to the extended exposure to high altitude.

2 Methods

2.1 Manaslu Expedition Profile

This study describes aspects of medical research performed during the Manaslu Himalaya expedition that has addressed a wide range of physiological issues connected with the fertility, metabolism, muscular changes, and physical performance in subjects exposed to chronic high-altitude hypoxia (Verratti et al. 2017; Doria et al. 2011; Pelliccione et al. 2011; Verratti et al. 2011; Mariggiò et al. 2010). There were seven healthy male climbers, members of the expedition, mean age 39 ± 15 years and height 1.72 ± 0.10 m, who were the subjects in the study framework presented herein.

There were several successive stages of the experimental procedure performed at variable altitude. The high-altitude stage was carried out in Nepal. After arriving in Kathmandu (1,300 m above sea level), the subjects were taken to the Buri Gandaki valley for the initiation of procedures. From there, an acclimatization trek was carried out along the Buri (Budhi) Gandaki River for 13 days, arriving at the Manaslu base camp at 5,000 m. Once at the camp, the subjects stayed there for 22 days without oxygen enrichment. During this time, they climbed Camp 1 (5,900 m) and then to Camp 2 (6,400 m) without oxygen. Finally, they took an 8-day trek back from the base camp to Kathmandu via an exceptionally difficult Larke Pass (5,135 m), covering in all about 450 km by the end of the expedition (Fig. 1).

Fig. 1
figure 1

Profile of the Manaslu expedition that lasted for 43 days, September 8–October 20, 2008

2.2 Anthropometry and Body Composition

The anthropometric characteristics such as body weight (BW), body mass index (BMI), waist circumference (WC), body fat (BF%), total lean body mass, and the thigh cross-sectional area (CSA) were obtained before and after the expedition in the Exercise Physiology Laboratory of Chieti-Pescara University in Italy, located at the altitude of 110 m above sea level. BF% and total lean body mass were estimated from the measurement of the subcutaneous skinfold thickness (Durnin and Womersley 1974). CSA was calculated from the equation:

CSA = (4.68 × thigh circumference in cm) − (2.09 × anterior thigh skinfold in mm) − 80.99 derived from the multiple regression analysis performed in a study of Housh et al. (1995) for estimation of thigh muscle CSA. Thigh circumference was measured approximately at a third of the trochanter-patella distance. These measurements were based on the previously elaborated methods available in the literature.

2.3 Blood Biomarkers

Venous blood samples were drawn at sea level before (SLB) and 2 days after (SLA) returning to Kathmandu, which ended the expedition. Sampling was performed at 8 am, after fasting for 12 h. The serum was collected for the measurement of biomarkers, and it was frozen in liquid nitrogen until use. The samples were immediately placed on ice and centrifuged for 10 min at 3000 rpm. The following biomarkers were measured leptin, insulin, C-reactive protein, homocysteine, and creatine kinase, myoglobin, and lactate dehydrogenase. Blood analysis was performed with the ADVIA Centaur CP Immunoassay System (Siemens Healthcare, Milan, Italy) in the Laboratory of Clinical Pathology of Teramo Hospital in Italy.

2.4 Dietary Intervention

The subjects did not follow any individualized dietary program before the expedition, except the instruction of a dietary intake of 2,000 kcal/day, with the following macronutrients content: carbohydrates 49%, proteins 25%, and lipids 26%, which was based on the software WinFood®-Medimatica-Italy. During the expedition, the subjects were instructed to consume about 3,600 kcal/day consisting of carbohydrates 50%, protein 30%, and fat 20% (Table 1).

Table 1 Breakdown of nutritional components by percentage before and during the expedition at high altitude

2.5 Statistical Elaboration

Data were presented as means ±SD. Data distribution was checked with the Kolmogorov-Smirnov test. Differences between the baseline measurements of indices and those after the expedition were compared with a two-tailed paired t-test or Wilcoxon’s test. A p-value <0.05 defined statistically significant changes. The analysis was performed with a commercial Statistica v8.0 package for Windows (StatSoft; Tulsa, OK).

3 Results

We found that chronic physical strain at high altitude caused substantial reductions in body mass and fat components assessed, with a simultaneous increase in CSA (Table 2). A total lean body mass remained unchanged.

Table 2 Anthropometric measurements performed at sea level before (SLB) and after (SLA) chronic high-altitude physical strain

Plasma level of leptin decreased by 38% after the stay at high altitude compared with the baseline level before the expedition, from 37.2 ± 11.8 to 23.0 ± 10.1 ng/mL, respectively, p < 0.05. This effect lost significance after normalization for FM due to a large spread of data, although a decreasing trend in leptin was there, from 1.8 ± 1.0 to 1.3 ± 0.5 ng/mL/kg of FM. Likewise, homocysteine decreased by 39%, from 4.74 ± 1.52 before to 2.89 ± 0.57 μmol/L after the expedition, p < 0.03 (Fig. 2).

Fig. 2
figure 2

Decreases in plasma level of leptin and homocysteine assessed at sea level before (SLB) and 2 days after (SLA) chronic high-altitude physical strain. Data are means ±SD

In contradistinction, myoglobin, insulin, and C-reactive protein showed increased significantly by 29%, 49%, and 26%, from 16.9 ± 3.4 to 21.8 ± 2.4 ng/mL, from 5.3 ± 2.1 to 7.9 ± 2.1 mcU/mL, and from 0.8 ± 0.2 to 1.0 ± 0.3 mg/dL, respectively, p < 0.05 for all (Fig. 3). Creatine kinase and lactate dehydrogenase decreased from 138.1 ± 60.9 to 117.1 ± 43.0 U/L and from 68.4 ± 40.8 to 47.7 ± 27.1 U/L; the decreases failed to reach statistical significance.

Fig. 3
figure 3

Increase in plasma level of insulin, myoglobin, and C-reactive protein (CRP) assessed at sea level before (SLB) and 2 days after (SLA) chronic high-altitude physical strain. Data are means ±SD

4 Discussion

Surprisingly, considering the reduction of FM in the climbers, it is interesting to note that insulin level increased. This increase could be secondary to FM reduction since the energy expenditure was not adequately compensated by the caloric intake during the trek. The FM reduction may have stimulated the release of a liposynthetic hormone, such as insulin, in an attempt to balance off a loss of fat. Larsen et al. (1997) have shown that healthy subjects exposed to hypobaric hypoxia at high altitude have hyperinsulinemia that persists for 1 week but reverts with the time of adaptation to low oxygen pressure. The literature suggests that a decrease in BW is generally associated with a decrease of leptin, while the opposite is true for BW excess (Benso et al. 2007; Broglio et al. 2006). In line with that notion, in this study we found a significant decrease in leptin content of about 38% compared with the baseline level before the expedition. A consistent decreasing trend of about 28% remained when leptin content was normalized for FM, even though it lost significance due to a large data spread.

In this study we found an increase in C-reactive protein, a marker of inflammation, while lactate dehydrogenase was unchanged. In addition, creatine kinase was unchanged, although we would have expected an increase in its content. The creatine kinase-related manifestation of muscle damage due to intensive trekking strain could possibly be masked by a short half-life of creatine kinase, amounting to about 1 day and a half. Creatine kinase increases in the first 12 h after onset of rhabdomyolysis, peaks within 3 days, returning to the baseline level in 3–5 days (Zhang 2012). Concerning homocysteine, the amino acid appreciably decreased by about 39%. Since a high-protein diet, in and by itself, does not alter fasting plasma total homocysteine content (Verhoef et al. 2005), it seems a reasonable assumption that a decrease in homocystein would reflect the exposure to chronic hypoxia. Bailey et al. (2000) have reported a decrease in homocysteine after hypoxic as opposed to normoxic physical training. An increase in the myoglobin level we demonstrate in this study is a normal adaptive response to training at high altitude. However, a persisting myoglobin enhancement may be a foretelling sign of muscle damage and dysfunction. This finding is consistent with the data reported by Nedergaard et al. (2013) and Hoppeler and Vogt (2001). In addition, high level of myoglobin is found in the populations living at high altitude, which probably belongs to the compensatory mechanisms of chronic exposure to hypoxic environment (Moore et al. 2002). A diet rich in calories, with a 30% protein content, has been highlighted as a fundamental nutritional intervention in sarcopenia (Woo 2018). On the other side, an increase in CSA of lower limbs with unchanged total lean body mass, we noticed in this study, is difficult to explain. We believe it might likely be the edema-forming redistribution of body fluids during chronic physical strain at high altitude. Trekkers are known to suffer from a moderate lower extremities edema that reverts on return to a lower altitude (Hultgren 1978).

In conclusion, the results of this study demonstrate that long strenuous trekking at high altitude is conducive to inflammatory response and exerts pro-cachexic and pro-sarcopenic effects. Degradation of muscle proteins, if sustained, may be a presage of muscular failure. These changes, in all likelihood, reflect the effects of exposure to chronic hypobaric hypoxia. A high caloric intake, in general, and a high protein diet, in particular, may at least partially counteract such untoward effects of high altitude hypoxia.